retatrutide dosage phase 2 trial VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide dosing schedule phase 2

Vilsbll T, Zdravkovic M, Le-Thi T, Krarup T, Schmitz O, Courrges JP et al (2007) Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

Youve probably heard about synthetic GLP-1 medications like Ozempic and Wegovy

Check the expiration date and look through the viewing window (or vial)

Mortality and major adverse cardiac events (MACE) with GLP-1 receptor agonists in psoriatic arthritis

This prevents contamination and preserves the integrity of the remaining solution

It's the needle